Product
HZ/su vaccine
Aliases
HZ/su vaccine (GSK1437173A)
2 clinical trials
1 indication
Indication
Herpes ZosterClinical trial
A Phase 3b, Open-label, Multi-country, Multi-centre, Long-term Follow-up Study of ZOSTER-049 (Follow-up of ZOSTER-006/022 Studies) to Assess the Prophylactic Efficacy, Safety and Persistence of Immune Response of a Herpes Zoster Subunit Vaccine and Assessment of Persistence of Immune Response and Safety of 1 or 2 Additional Doses Administered in ZOSTER-049 in 2 Subgroups of Older AdultsStatus: Active (not recruiting), Estimated PCD: 2027-08-23
Clinical trial
Long-term Immunogenicity Study of Herpes Zoster Subunit Vaccine (GSK1437173A) and Immunogenicity and Safety Assessment of Revaccination With Two Additional Doses in Adults With Renal Transplant From Study ZOSTER-041Status: Active (not recruiting), Estimated PCD: 2022-08-12